Restricted mean survival time: Does covariate adjustment improve precision in randomized clinical trials?

Comparison of Treatment Effects Measured by the Hazard Ratio and by the Ratio of Restricted Mean Survival Times in Oncology Randomized Controlled Trials

(2016) Ludovic Trinquart et al.   JOURNAL OF CLINICAL ONCOLOGY

Describing Differences in Survival Curves

(2016) Rick Chappell et al.   JAMA Oncology

Alternatives to Hazard Ratios for Comparing the Efficacy or Safety of Therapies in Noninferiority Studies

(2015) Hajime Uno et al.   ANNALS OF INTERNAL MEDICINE

Fitting Accelerated Failure Time Models in Routine Survival Analysis withRPackageaftgee

(2015) Sy Han Chiou et al.   Journal of Statistical Software

Phase III Randomized Trial of Induction Chemotherapy in Patients With N2 or N3 Locally Advanced Head and Neck Cancer

(2014) Ezra E.W. Cohen et al.   JOURNAL OF CLINICAL ONCOLOGY

Moving Beyond the Hazard Ratio in Quantifying the Between-Group Difference in Survival Analysis

(2014) Hajime Uno et al.   JOURNAL OF CLINICAL ONCOLOGY

On adjustment for auxiliary covariates in additive hazard models for the analysis of randomized experiments

(2013) S. Vansteelandt et al.   BIOMETRIKA

Restricted mean survival time: an alternative to the hazard ratio for the design and analysis of randomized trials with a time-to-event outcome

(2013) Patrick Royston et al.   BMC Medical Research Methodology

Covariate adjustment for two-sample treatment comparisons in randomized clinical trials: A principled yet flexible approach

(2007) Anastasios A. Tsiatis et al.   STATISTICS IN MEDICINE